Insider sale logged at Teva (NYSE: TEVA) — 80,762 shares and 23,251 RSUs noted

Rhea-AI Filing Summary

Teva Pharmaceutical Industries Limited Form 144 lists a proposed sale of ordinary shares to be handled through Citigroup Global Markets. The filing also records a prior sale by Eric Hughes of 80,762 shares on 03/03/2026 for $2,613,450.24 and a restricted share unit award of 23,251 scheduled with a 03/04/2026 vesting/compensation reference.

Insights

Securities Counsel

Form 144 records a proposed resale of Teva ordinary shares and prior insider activity.

The notice lists Citigroup Global Markets as the broker and details a past sale by Eric Hughes of 80,762 shares on 03/03/2026 for $2,613,450.24. It also shows a RSU-related line for 23,251 units with a 03/04/2026 reference.

Timing and aggregate offering mechanics are not described in the excerpt; any resale under Rule 144 will be subject to statutory conditions and the broker's distribution plan.

Equity Markets Analyst

Reported past sale size and RSU vesting are modest and routine for an equity filing.

The filing documents a discrete insider sale of 80,762 shares and a compensation vesting entry of 23,251 RSUs with explicit dates, indicating individual holder activity rather than a company-wide offering.

This type of Form 144 notice typically signals holder resale intent; subsequent filings would disclose execution details if and when transactions occur.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	11277	366102.17	1149812898	03/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	03/04/2024	RESTRICTED SHARE UNIT AWARD VESTING EM	TEVA PHARMACEUTICAL INDUSTRIES LIMITED			23251	03/04/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ERIC HUGHES 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020	ORDINARY SHARES	03/03/2026	80762	2613450.24

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Teva's Form 144 list regarding insider sales?

It lists a proposed resale of ordinary shares via Citigroup Global Markets and records a prior sale of 80,762 shares on 03/03/2026 for $2,613,450.24. The filing also shows a 23,251 RSU compensation entry with a 03/04/2026 reference.

Who filed the prior sale recorded in the TEVA Form 144 excerpt?

The prior sale was recorded under the name Eric Hughes, showing a sale of 80,762 shares on 03/03/2026 with proceeds listed as $2,613,450.24 in the excerpt.

Does the filing state which broker will handle the resale for TEVA shares?

Yes, the excerpt lists Citigroup Global Markets at 390 Greenwich St, New York, and associates it with the ordinary shares entry in the Form 144 excerpt.

Are restricted stock units mentioned in the TEVA Form 144 excerpt?

Yes, the excerpt includes a line reading 'RESTRICTED SHARE UNIT AWARD VESTING EM' with a quantity of 23,251 and a date of 03/04/2026, labeled as COMPENSATION.

Does the excerpt show the total number of shares being registered for resale?

The excerpt does not present an explicit aggregate registered offering total; it lists broker details, a past sale by Eric Hughes, and a 23,251 RSU entry without an overall resale aggregate figure.